Everest Group Life Sciences Clinical Data and Analytics (D&A)
Platforms PEAK Matrix® Assessment 2024
Focus on eClinical Solutions
November 2024
Introduction
Clinical trials are becoming increasingly complex due to decentralized and hybrid trial designs, which generate vast volumes of data from numerous sources. In this evolving landscape, sponsors are progressively turning to unified clinical data and analytics platforms for effective data management and informed decision-making.
These platforms offer a range of benefits such as consolidating diverse data types into a centralized repository, transforming this data into standardized formats, enabling real-time monitoring for various stakeholders, detecting outliers and signals, predicting adverse events, and generating customized reports and dashboards. Thus, they address sponsor challenges right from data ingestion to insight generation. Additionally, platform providers are incorporating AI and generative AI capabilities to automate routine tasks, generate insights, and enhance quality and risk management.
In the report, we assess the capabilities of 18 platform providers specific to clinical D&A. These platform providers are mapped on the Life Sciences Clinical Data and Analytics (D&A) Platforms PEAK Matrix® Assessment 2024, which is a composite index of a range of distinct metrics related to a provider’s capability and market impact.
The full report includes the profiles of the following 18 leading clinical D&A providers featured on the clinical D&A platforms PEAK Matrix:
Leaders: eClinical Solutions, Medidata Solutions, and Saama
Major Contenders: AlphaLife Sciences, EDETEK, Emmes, IQVIA, Lokavant, MaxisIT, Oracle, TCS, ThoughtSphere, Veeva, and Zelta (Merative)
Aspirants: Adaptive Clinical Systems, Axiom Real-time Metrics, NextTrial AI, and Signant Health
Scope of this report
Geography: Global
Industry: Life sciences (biopharmaceuticals, medical devices, and Contract Research Organizations (CROs))
Products: Clinical D&A Platforms
Life sciences clinical data and analytics platforms PEAK Matrix® characteristics
Leaders
eClinical Solutions, Medidata Solutions, and Saama
Leaders possess end-to-end clinical data and analytics capabilities, offering customizable, configurable, and scalable platform that incorporates low-code/no-code functionalities
Leaders showcase strong thought leadership and industry presence, benefiting from strong brand recall by clients
Leaders are focused on enhancing their functionalities and distinguishing themselves through the adoption of next-generation technologies such as AI, ML, and gen AI
Leaders have strong data ingestion and management capabilities, combined with AI/ML powered data review and customizable visualizations
Major Contenders
AlphaLife Sciences, EDETEK, Emmes, IQVIA, Lokavant, MaxisIT, Oracle, TCS, ThoughtSphere, Veeva, and Zelta (Merative)
Major Contenders offer best-in-class solutions targeting specific areas of the data and analytics value chain but have opportunities to expand more capabilities such as next-generation technologies, Risk-based Quality Management (RBQM), and Statistical Computing Environment (SCE)
Some Major Contenders are actively investing in and developing various AI and gen AI use cases to differentiate themselves
Major Contenders focus on a diverse range of buyer sizes, offering flexible pricing models
Some Major Contenders lack on the platform's data integration speed and scalability, and on robust partnerships with consulting firms and peer providers
Aspirants
Adaptive Clinical Systems, Axiom Real-time Metrics, NextTrial AI, and Signant Health
Aspirants primarily offer point solutions in specific clinical data and analytics segments
Aspirants lack strong partnerships for data integrations, analytics, implementation, and change management
Aspirants lack market awareness and visibility among clients
Everest Group PEAK Matrix®
eClinical Solutions profile (page 1 of 13)
Overview
Company mission/vision statement for clinical D&A platforms
eClinical Solutions' advanced D&A platform, along with its biometrics services, supports biopharma researchers in managing trial complexities efficiently across large, midsized, and emerging life sciences organizations. The platform provides accurate, timely data insights that enhance decisionmaking, shorten cycle times, boost productivity, and facilitate scalable operations to drive future breakthroughs. With the elluminate Clinical Data Cloud® ’s automated data pipeline, integrated AI/ML features, and scalable infrastructure, organizations can navigate the challenges of modern clinical trials and deliver substantial value across development functions.
Overview of the client base
eClinical Solutions' elluminate Clinical Data Cloud® is utilized by more than 80 life sciences companies across the US and Europe. Its client base includes a range of industry segments, from midsized to large biotech and pharmaceutical firms, encompassing 16 of the top 50 life sciences companies.
Clinical D&A platforms revenue mix
eClinical Solutions profile (page 2 of 13)
Case studies
CASE STUDY 1
Streamlined clinical trials and data management with elluminate® for a global biopharmaceutical company with a focus on oncology and neuroscience
Business challenge
The client managed numerous clinical trials worldwide, collaborating with various vendors and Contract Research Organizations (CROs). This extensive network involved multiple data management systems and formats across trial sites, leading to complex data management challenges. It aimed to streamline its clinical trial operations to enhance internal resource utilization, reduce trial cycle times, and avoid costly protocol amendments. It wanted to develop a Clinical Data Factory (CDF) to consolidate clinical data, standardize it, and boost data efficiency and quality.
Solution
Partnered with eClinical Solutions to deploy elluminate data cloud for Clinical Data Factory (CDF)
Utilized the versatile and configurable elluminate® platform, a cloud-based SaaS solution, automated the data standardization process using Mapper, reducing manual efforts and enabling the publication of curated data for advanced analytics
Centralized trial data review with Data Central, providing a real-time, holistic view of data from all sources and improving oversight, enabled early issue detection through centralized data review
Transformed data into actionable insights with Clinical Analytics, using visualizations and workflow management to facilitate quicker decision-making and proactive risk management
Impact
Minimized time spent on monitoring data quality, which led to faster clinical trial completion
Decreased time required for data standardization, improving overall resource efficiency
Detected potential issues more quickly, through effective dashboards and usage metrics
Reduced study closeout efforts by three to four weeks per study due to enhanced data review and issue management, achieved a seven-day Database Lock (DBL) milestone as part of the 2024 initiative
Saved on full-time equivalent employees by streamlining programming requests and workflows, leveraging elluminate® ’s data review capabilities
CASE STUDY 2
Facilitated data management and analysis with elluminate Clinical Data Cloud® for a leading science and technology company in Germany
Business challenge
The client faced significant issues with its legacy data platform, which no longer met the needs of various user groups across the organization. Feedback from internal teams indicated that the platform was inadequate for handling increasing volumes and velocities of data. To address these concerns and ensure future readiness, the client initiated a comprehensive review process. This involved gathering detailed feedback from over 30 global stakeholders through one-on-one interviews and surveying more than 100 additional users. The feedback focused on the limitations of the existing platform and the desired features for a new, more effective solution.
Solution
Selected with the elluminate Clinical Data Cloud® to enhance user access, analysis, and interaction with data using the chosen solution
Implemented the elluminate® platform to provide trial stakeholders with efficient, user-friendly data management tools
Facilitated better utilization of both internal and external data sources
Supported future trials with advanced capabilities of the elluminate® platform
Impact
Simplified and intuitive user interfaces across teams facilitating real-time data integration, curation, and harmonization
Enhanced interoperability with other clinical research data technologies
Improved data access, leading to better decision-making and appropriate use of data
Optimized oversight and auditing through comprehensive traceability and knowledge management
Increased flexibility for data exploration while maintaining data security and preservation
Provided plug-and-play analytical tools that transformed data into actionable insights and integrated input from various sources
eClinical Solutions profile (page 3 of 13)
Summary
of capabilities and features
Enterprise clinical data management
Clinical analytics
Clinical data integration from multiple sources (EHR, EDC, CTMS, LIMS, eCOA/ePRO, devices, etc.)
Metadata management (data lineage, data catalog, metadata discovery, extraction, indexing, etc.)
Missing data imputation
Descriptive modeling
Support for next-generation tech (ML, AI, NLP, and Gen AI)
Statistical tools and computing environment
Risk-based Quality Management (RBQM)
Data mapping
Data model and library management
KPI monitoring/reporting, and intelligent business alerts
Pre-trained models for specific clinical use cases
Clinical data workflow automation
Data storage and administration
Data modernization, DataOps, etc.
Capability/feature available [NOT EXHAUSTIVE]
Data validation, standardization, and harmonization
Capability/feature not available
Data pre-processing and cleaning for enhanced quality (data profiling, cleansing, enhancement, etc.)
Data blinding, anonymization, and pseudonymization
Anomaly detection and alerting mechanism
Integrated patient view
Predicting outcomes (e.g., patient outcomes)
Support for common statistical tests and analyses
Centralized Statistical Monitoring (CSM) Key Risk Indicators (KRIs)
Protocol design
Next-best-action suggestion
Survival analysis and other specialized techniques
Quality Tolerance Limits (QTLs)
Data migration
Data quality and completeness
Explainability and interpretability of Gen AI results
Pre-built libraries and templates for common analyses
Risk Assessment and Categorization Tool (RACT)
eClinical Solutions profile (page 4 of 13)
Summary of capabilities and features
Visualization and reporting capabilities Interactive dashboards and reports (customizable charts, graphs and heatmaps for site and overall trial performance)
Context-sensitive help and tutorials
Flexible reporting formats (tabular, narrative, visualizations)
Drill-down functionality for deeper exploration (filtering, sorting, etc.)
Accessibility features for diverse users
Automated report generation and scheduling
Integration with external data visualization tools
Capability/feature available
Data validation, standardization, and harmonization
[NOT EXHAUSTIVE]
Capability/feature not available
Data export options (PDF, CSV, Excel, Word)
Interactive and mobile BI
Real-time collaboration and communication tools for sharing insights (sharing and collaboration features)
Role-based dashboards and reports
KPI monitoring/reporting, and intelligent business alerts
eClinical Solutions profile (page 5 of 13)
Product capabilities and features
Product capabilities and features
Product capabilities/features Details
Importer – clinical data integration from multiple sources (EHR, EDC, CTMS, LIMS, eCOA/ePRO, devices, etc.)
Metadata Repository (MDR), Standards Module, Validator – metadata management (data lineage, data catalog, metadata discovery, extraction, indexing, etc.)
eIQ Review (part of Data Central) –missing data imputation
elluminate Mapper – data mapping
Clinical Data Repository (CDR), Standards Module, Validator – data model and library management
eIQ Review (part of Data Central) –anomaly detection and alerting mechanism
Clinical Data Repository (CDR) –data storage and administration
[REPRESENTATIVE LIST] [NOT EXHAUSTIVE]
It includes elluminate Importer that simplifies data ingestion by allowing organizations to import data from a wide range of sources including various file types such as SAS, Excel, CSV, and XML. It seamlessly combines and standardizes this data with other sources, making it readily available for comprehensive and powerful analytics within the elluminate platform.
It utilizes a suite of features within elluminate to ensure effective data governance. elluminate can import and enforce both industry- and sponsor-specific standards, and it captures and stores metadata for every file upon ingestion. During subsequent data imports, elluminate compares this metadata to identify any deviations throughout the data feed's life cycle.
It offers eIQ Review that leverages AI and ML to identify anomalies that traditional review methods might miss, allowing data management teams to concentrate on the most crucial data. It utilizes various models to detect incorrect or missing data across multiple domains.
It leverages elluminate Mapper, an intuitive application featuring a drag-and-drop interface designed for users without programming skills. It enables quick integration of multiple data sources, facilitates intricate transformations to SDTM and other standard formats, and allows for the publication of refined data for analytical purposes.
It uses elluminate to provide a Standards module designed for standards experts to efficiently upload, manage, and maintain data standards. This includes both CDISC and custom standards, which can be uploaded through local files (such as CSV) or integrated from MDRs such as Formedix or Nurocor.
The eIQ Review leverages AI and ML to identify anomalies that traditional review methods might miss, allowing data management teams to concentrate on the most crucial data.
It includes leveraging elluminate, a comprehensive clinical data platform, that efficiently imports data from various sources, transforms, and standardizes it, and then delivers it for targeted, role-based clinical and operational analytics. elluminate is a clinical data repository that houses and aggregates data from disparate systems.
eClinical Solutions profile (page 6 of 13)
Product capabilities and features
Product capabilities and features
Product capabilities/features Details
Clinical Data Repository (CDR) –data blinding, anonymization, and pseudonymization
Validator – data validation, standardization and harmonization
Data Central – data pre-processing and cleaning for enhanced quality (data profiling, cleansing, enhancement, etc.)
Importer / Mapper – data migration
[REPRESENTATIVE LIST] [NOT EXHAUSTIVE]
It includes leveraging elluminate to enable the configuration of multiple data stores within a study, allowing users and administrators to distinguish between blinded and non-blinded data while assigning specific permissions to each data store.
It involves using Validator, a utility designed to ensure data conforms to existing or custom CDISC standards. It assesses data from imports or domain mappings, verifying the presence of required variables and identifying any variables that are included but not part of the standard.
It involves Data Central, a clinical data management software that enables data managers and medical reviewers to efficiently manage study data and resolve issues collaboratively. By using in-stream data review, it creates high-quality databases without requiring access to multiple disparate systems, spreadsheets, or listings.
eIQ Review (part of Data Central) –support for next-gen tech (ML, AI, NLP, and generative AI)
elluminate SCE – statistical tools and computing environment
elluminate RBQM – Risk-based Quality Management (RBQM)
It involves exporting and importing system-level configuration items such as studies, import definitions, data stores, tags, and marking groups across multiple environments.
It includes elluminate IQ that provides AI-enabled data-review capabilities for improved data quality and efficiency at scale. There are several use cases deployed that collectively automate over 25 clinical data review objectives.
It involves the elluminate Statistical Computing Environment (SCE), which centralizes all data, metadata, programs, and results to enhance efficiency, traceability, and visibility in statistical analyses. It is fully integrated within the elluminate Clinical Data Cloud®, which enables greater accessibility, interoperability, and reusability of data.
It involves the optional elluminate RBQM feature set within Data Central, which enables users to monitor study, geographic, and site risks through traditional methods, centralized statistical monitoring, and advanced statistical models. It allows users to seamlessly transition from an analytics drill-down dashboard to examining the underlying data, thereby understanding the root causes before taking action.
eClinical Solutions profile (page 7 of 13)
Product capabilities and features
Product capabilities and features
Product capabilities/features Details
Issues Management (embedded across the platform – Data Central, eIQ Review, Clinical Analytics, Operational Insights, RBQM, SCE)
eIQ Review (part of Data Central) –pre-trained models for specific clinical use cases
elluminate Platform (embedded across the platform) – clinical data workflow automation
elluminate RBQM, eIQ Review – centralized Statistical Monitoring (CSM)
[REPRESENTATIVE LIST] [NOT EXHAUSTIVE]
An issue can be created from a record, listing, or graphical patient profile within Data Central, eIQ Review, from a sheet within Clinical Analytics, manually created in RBQM, system-generated from RBQM based on configured actions, from a form or record within a panel grid (listing) in the Operational Data Repository, from specifications, and from a file in the SCE. Issues can be actioned from the listing individually, or multiple issues can be actioned at one time.
It offers pre-trained models that are ready to use and support more than a dozen clinical data review scenarios out of the box.
Data Central – integrated patient view
elluminate SCE – support for common statistical tests and analyses
elluminate RBQM –Key Risk Indicators (KRIs)
It offers a comprehensive workflow management system designed to handle data ingestion, mapping, review, and analysis through elluminate. The platform’s workflows are fully automated and customizable to meet specific business needs. Task automation throughout the system enables data on demand by streamlining actions within the platform.
It is possible to use Key Risk Indicators (KRIs) in elluminate RBQM either through traditional scoring methods or by leveraging elluminate’s Centralized Statistical Monitoring (CSM) for advanced statistical analysis. This approach allows for the differentiation of areas of concern and insignificant changes in study data based on statistical significance and can automatically initiate follow-up actions. In eIQ Review, the CSM’s subject-level univariate anomaly detection model identifies subjects with unusual lab results or vital signs.
It involves elluminate Data Central, a comprehensive data management workbench that consolidates all data types and sources from a clinical trial into a unified platform. This solution facilitates real-time data review, oversight, and issue management by enabling data managers, medical reviewers, coders, safety personnel, and clinical staff to collaborate effectively.
It leverages the elluminate Statistical Computing Environment (SCE), which centralizes data, metadata, programs, and results to enhance efficiency, traceability, and visibility in statistical analyses
It involves configuring KRIs within elluminate RBQM. These KRIs are continuously updated through elluminate’s automation engine. When a site reaches a specific risk level, an action is triggered, such as notifying the CRA to arrange a visit. Additionally, elluminate’s eCS offers a library of QTLs and KPIs across various therapeutic areas including oncology and immunology, based on extensive experience.
eClinical Solutions profile (page 8 of 13)
Product capabilities and features
Product capabilities and features
Product capabilities/features Details
Data Central, Clinical Analytics – protocol design
elluminate RBQM – Quality Tolerance Limits (QTLs)
Data Central – data quality and completeness
elluminate SCE – pre-built libraries for common analyses
Data Central, Clinical Analytics, Operational Insights, RBQM, Sample Management Analytics – interactive dashboards and reports
elluminate Online Help Center – contextsensitive help and tutorials
Data Central, Clinical Analytics –flexible reporting formats (tabular, narrative, visualizations)
[REPRESENTATIVE LIST] [NOT EXHAUSTIVE]
Intelligent trial designs are informed by leveraging the past protocol data and deviations captured and available within elluminate.
It involves the use of elluminate RBQM's user-friendly configuration environment to define and monitor QTLs. When risk thresholds are approached during a study, automatic issues are generated and assigned to specific users for resolution. Additionally, eCS offers a comprehensive library of QTLs/KRIs across various therapeutic areas such as oncology and immunology based on our extensive experience.
It enables data managers and medical reviewers to seamlessly collaborate within the clinical data management software, facilitating efficient study data management and prompt resolution of queries and data issues. It ensures the creation of a high-quality database through in-stream data review, eliminating the need to navigate multiple disparate systems, spreadsheets, and listings.
It offers a fully integrated code editor within elluminate SCE, providing comprehensive version control, collaborative editing and review capabilities, and complete tracking of the software development life cycle. It also includes access to a global library of reusable code, allowing users to efficiently manage and utilize code snippets, macros, and functions.
elluminate utilizes a robust data visualization environment for presenting clinical and operational analytics including standard visualizations as well as any customized visualizations that can be configured in Mapper for specific roles. Visualizations have role-based permissions and include the ability to create and assign issues for further investigation and follow up directly from the visualizations.
The elluminate online Help Center provides a robust library of tutorials and tips for all elluminate users. The available resources can be sorted by user persona and products/capabilities.
It includes fully customizable tabular and graphical patient profiles that can be accessed directly within the elluminate platform or exported into Excel or PDF formats. Users have the flexibility to create their own reports by utilizing existing out-of-the-box options or by generating new visualizations. Additionally, eClinical can offer this service on behalf of the sponsor.
eClinical Solutions profile (page 9 of 13)
Product capabilities and features
Product capabilities and features
Product capabilities/features Details
[REPRESENTATIVE LIST] [NOT EXHAUSTIVE]
Drill-down functionality for deeper exploration Data visualizations throughout the platform allow for easy drilling in and out, selection of subsets, filtering, and maintaining these settings as a user navigates through domains and displays, allowing the data to tell the story of the trial.
elluminate Platform – accessibility features for diverse users
elluminate Platform – automated report generation and scheduling
elluminate Platform – integration with external data visualization tools
elluminate offers a very comprehensive and granular set of privileges to control the specific data stores, features, and data that users or groups can access including role-based access and least-privileges methodology across all products/capabilities within elluminate. Access can be controlled at the therapeutic area, compound, program, study, and data store levels.
It includes task automation that delivers data on demand by automating actions such as report generation within elluminate. Users can schedule reports to run automatically from the Reports listing page, with Report Definitions set to execute at specified times.
It includes elluminate's adapters and data export capabilities, which make aggregated and validated data accessible for downstream applications. Its solution integrates with big data cloud platforms such as Snowflake, allowing seamless data consumption for visualization tools. This means that elluminate data can be utilized not only through proprietary products such as data central, clinical data analytics, clinical trial operational analytics, and operational insights but also through other visualization software including Spotfire, Tableau, and PowerBI.
elluminate Platform – interactive and mobile BI It includes a cloud-based Software-as-a-Service (SaaS) solution that is configurable to meet diverse client needs. Under this model, customers do not need to handle any hosting or infrastructure. Users can access the system through a standard web browser without the need for special software or hardware, and there are no external dependencies. The platform is hosted in the Amazon Web Services (AWS) Cloud.
Exporter – data export options (PDF, CSV, Excel, Word)
It includes the ability to export specific domains or entire studies. Exports can be performed manually or scheduled using predefined export definitions, allowing selections to be saved for future use. Available export formats include Excel, CSV, SAS, SAS XPORT, and Delimited.
Mapper – drag-and-drop feature It enables non-programmers to integrate various data sources, execute complex transformations to SDTM and other standard formats, and publish curated data for analytics.
eClinical Solutions profile (page 10 of 13)
Product capabilities and features
Product capabilities and features
Product capabilities/features Details
Issues Management (across the platform) stories
elluminate Platform – role-based dashboards, reports
[REPRESENTATIVE LIST] [NOT EXHAUSTIVE]
It includes the ability to create issues from various sources such as records, listings, graphical patient profiles within Data Central, eIQ Review, clinical analytics sheets, RBQM, operational data repository panels, specifications, or files in the SCE. Issues can be addressed individually from the listing or in bulk. Comments can be added to records that are not actionable or have associated workflows. Additionally, stories allow for the sharing of data discoveries by building narratives from visualizations in Clinical Analytics. It combines reporting, presentation, and exploratory analysis to create and share collaborative insights.
It includes a detailed privilege management system that governs access to specific data stores, features, and datasets within elluminate. The solution applies role-based access and a least-privileges approach across all products. Access can be regulated at multiple levels including therapeutic area, compound, program, study, and data store.
eClinical Solutions profile (page 11
of 13)
Recent developments
[REPRESENTATIVE LIST] [NOT EXHAUSTIVE] Key events
Event name Type of event Details
Investment from GI partners Investment GI Partners, a private investment firm, makes majority investment in eClinical Solutions in 2024, to fuel eClinical’s next phase of growth, deepen the product roadmap, extend embedded AI, and drive future-ready trials
Strategic partnership Partnership Partnered with Snowflake in 2024 to integrate elluminate with Snowflake, enabling data sharing between sponsors, CROs, and eClinical Solutions
Technology partnerships Partnership Formed new technology partnerships in 2024 to build an ecosystem that addressed the current and future needs of clinical research through collaborations with Flatiron, Snowflake, Databricks, and others
SI and consulting partnerships Partnership In 2024, established new SI and management consulting partnerships with global SIs such as Capgemini, and expanded collaborations with providers, such as Accenture to enhance talent availability in the market, thereby improving client service
SI and consulting partnerships Partnership Launched a new partnership model for SIs and consulting partners in 2024, aimed at creating an ecosystem to support the implementation and managed services of elluminate; the model also assisted with program management and change management support for clients in need
Strategic partnership Partnership Partnered with Flatiron in 2023 to address RWE/RWD use cases
Certification Trainings/ Certifications Achieved ISO 27001:2022 and 27701:2019 certification for its Information Security Management System (ISMS) and Privacy Information Management Systems (PIMS) from the International Standards Organization (ISO) in 2023
New product Innovation Introduced eIQ Orchestrator in 2023, an automated rules management interface integrated into the elluminate Clinical Data Cloud®
elluminate accreditation Trainings/ Certifications It launched the elluminate accreditation for clients and partners in 2023, certifying expertise in configuring and using the elluminate platform
New product Innovation Released the Statistical Computing Environment (SCE) as part of the elluminate Clinical Data Cloud® in 2022
New product Innovation Released elluminate IQ in 2022, which provides AI-enabled data review capabilities
eClinical Solutions profile
(page 12 of 13)
Recent developments
[REPRESENTATIVE LIST] [NOT EXHAUSTIVE]
Key events
Event name
DCT partnership Partnership Partnered with Medable in 2022 to support clients in implementing and strategizing Decentralized Clinical Trial (DCT) technology
2022 growth Others Achieved a 100% Year-over-Year (YoY) increase in elluminate Clinical Data Cloud® software in 2022
New product Innovation Introduced RBQM as part of the elluminate Clinical Data Cloud® in 2021
eClinical Solutions profile (page 13 of 13)
Everest Group assessment – Leader
Measure of capability: High Low
Market impact
Market adoption Portfolio mix Value delivered Overall
Vision and strategy Technology capability
Vision and capability
Flexibility and ease of deployment Engagement and commercial model Support Overall
Strengths
eClinical Solutions offers a platform with end-to-end capabilities across the clinical data value chain, from data ingestion to visualization
Clients appreciate the User Interface (UI) and ease of use of the platform
Clients appreciate the platform’s robust data integration capabilities, which enable it to ingest data from multiple data collection systems
eClinical Solutions leverages a comprehensive partnership ecosystem, consisting of various categories of partner firms such as Real-World Data (RWD), EDC, electronic Trial Master File (eTMF) providers, system integrators, consulting firms, and Decentralized Clinical Trials (DCT) platform providers
Clients appreciate the platform’s ease of deployment, flexibility, and scalability
eClinical Solutions is increasing its focus on deploying multiple AI and gen AI use cases including automated data mapping, data classification, anomaly detection, and conversational analytics
Limitations
Clients want the turnaround time for eClinical Solutions’ support services to be faster in order to achieve quicker resolution of issues
Some clients feel that eClinical Solutions does not fully engage as a strategic and consultative partner and believe there is room for improvement in this area
Clients indicate a need for the eClinical Solutions’ technical team to improve its domain expertise to better understand client concerns
eClinical Solutions can work on improving the awareness of its AI and gen AI use cases among the clients
Matrix® framework
Everest Group PEAK Matrix® is a proprietary framework for assessment of market impact and vision and capability
Everest Group PEAK Matrix
Market impact Measures impact created in the market
Major Contenders
Leaders
Aspirants
Vision and capability Measures ability to deliver products successfully
Products PEAK Matrix® evaluation dimensions
Measures impact created in the market –captured through three subdimensions
Market adoption
Number of clients, revenue base, and YoY growth
Portfolio mix
Diversity of client base across industries, geographies, environments, enterprise size class
Value delivered
Value delivered to the client based on customer feedback and other measures
Major Contenders Leaders
Vision and strategy
Vision for the client and itself; future roadmap and strategy
Vision and capability
Measures ability to deliver products successfully. This is captured through five subdimensions
Technology capability
Technical sophistication and breadth/depth across the technology suite
Flexibility and ease of deployment
Configurability/customize-ability, hosting and tenancy, integration, governance, and security and compliance
Engagement and commercial model
Progressiveness, effectiveness, and flexibility of engagement and commercial models
Support
Training, consulting, maintenance, and other support services
Aspirants
Q: Does the PEAK Matrix® assessment incorporate any subjective criteria?
A: Everest Group’s PEAK Matrix assessment takes an unbiased and fact-based approach that leverages provider / technology vendor RFIs and Everest Group’s proprietary databases containing providers’ deals and operational capability information. In addition, we validate/fine-tune these results based on our market experience, buyer interaction, and provider/vendor briefings.
Q: Is being a Major Contender or Aspirant on the PEAK Matrix, an unfavorable outcome?
A: No. The PEAK Matrix highlights and positions only the best-in-class providers / technology vendors in a particular space. There are a number of providers from the broader universe that are assessed and do not make it to the PEAK Matrix at all. Therefore, being represented on the PEAK Matrix is itself a favorable recognition.
Q: What other aspects of the PEAK Matrix assessment are relevant to buyers and providers other than the PEAK Matrix positioning?
A: A PEAK Matrix positioning is only one aspect of Everest Group’s overall assessment. In addition to assigning a Leader, Major Contender, or Aspirant label, Everest Group highlights the distinctive capabilities and unique attributes of all the providers assessed on the PEAK Matrix. The detailed metric-level assessment and associated commentary are helpful for buyers in selecting providers/vendors for their specific requirements. They also help providers/vendors demonstrate their strengths in specific areas.
Q: What are the incentives for buyers and providers to participate/provide input to PEAK Matrix research?
A: Enterprise participants receive summary of key findings from the PEAK Matrix assessment
For providers
The RFI process is a vital way to help us keep current on capabilities; it forms the basis for our database – without participation, it is difficult to effectively match capabilities to buyer inquiries
In addition, it helps the provider/vendor organization gain brand visibility through being in included in our research reports
Q: What is the process for a provider / technology vendor to leverage its PEAK Matrix positioning?
A: Providers/vendors can use their PEAK Matrix positioning or Star Performer rating in multiple ways including:
Issue a press release declaring positioning; see our citation policies
Purchase a customized PEAK Matrix profile for circulation with clients, prospects, etc. The package includes the profile as well as quotes from Everest Group analysts, which can be used in PR
Use PEAK Matrix badges for branding across communications (e-mail signatures, marketing brochures, credential packs, client presentations, etc.)
The provider must obtain the requisite licensing and distribution rights for the above activities through an agreement with Everest Group; please contact your CD or contact us
Q: Does the PEAK Matrix evaluation criteria change over a period of time?
A: PEAK Matrix assessments are designed to serve enterprises’ current and future needs. Given the dynamic nature of the global services market and rampant disruption, the assessment criteria are realigned as and when needed to reflect the current market reality and to serve enterprises’ future expectations.
Stay connected
Dallas (Headquarters)
info@everestgrp.com
+1-214-451-3000
Bangalore
india@everestgrp.com
+91-80-61463500
Website everestgrp.com
Blog everestgrp.com/blog
Delhi
india@everestgrp.com
+91-124-496-1000
Follow us on
London
unitedkingdom@everestgrp.com
+44-207-129-1318
Toronto
canada@everestgrp.com
+1-214-451-3000
Everest Group is a leading research firm helping business leaders make confident decisions. We guide clients through today’s market challenges and strengthen their strategies by applying contextualized problem-solving to their unique situations. This drives maximized operational and financial performance and transformative experiences. Our deep expertise and tenacious research focused on technology, business processes, and engineering through the lenses of talent, sustainability, and sourcing delivers precise and action-oriented guidance. Find further details and in-depth content at www.everestgrp.com.
Notice and disclaimers
Important information. Please review this notice carefully and in its entirety. Through your access, you agree to Everest Group’s terms of use.
Everest Group’s Terms of Use, available at www.everestgrp.com/terms-of-use/, is hereby incorporated by reference as if fully reproduced herein. Parts of these terms are pasted below for convenience; please refer to the link above for the full version of the Terms of Use.
Everest Group is not registered as an investment adviser or research analyst with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (FINRA), or any state or foreign securities regulatory authority. For the avoidance of doubt, Everest Group is not providing any advice concerning securities as defined by the law or any regulatory entity or an analysis of equity securities as defined by the law or any regulatory entity.
All Everest Group Products and/or Services are for informational purposes only and are provided “as is” without any warranty of any kind. You understand and expressly agree that you assume the entire risk as to your use and any reliance upon any Product or Service. Everest Group is not a legal, tax, financial, or investment advisor, and nothing provided by Everest Group is legal, tax, financial, or investment advice. Nothing Everest Group provides is an offer to sell or a solicitation of an offer to purchase any securities or instruments from any entity. Nothing from Everest Group may be used or relied upon in evaluating the merits of any investment. Do not base any investment decisions, in whole or part, on anything provided by Everest Group.
Products and/or Services represent research opinions or viewpoints, not representations or statements of fact. Accessing, using, or receiving a grant of access to an Everest Group Product and/or Service does not constitute any recommendation by Everest Group that recipient (1) take any action or refrain from taking any action or (2) enter into a particular transaction. Nothing from Everest Group will be relied upon or interpreted as a promise or representation as to past, present, or future performance of a business or a market. The information contained in any Everest Group Product and/or Service is as of the date prepared, and Everest Group has no duty or obligation to update or revise the information or documentation. Everest Group may have obtained information that appears in its Products and/or Services from the parties mentioned therein, public sources, or third-party sources, including information related to financials, estimates, and/or forecasts. Everest Group has not audited such information and assumes no responsibility for independently verifying such information as Everest Group has relied on such information being complete and accurate in all respects. Note, companies mentioned in Products and/or Services may be customers of Everest Group or have interacted with Everest Group in some other way, including, without limitation, participating in Everest Group research activities.
